Similar articles

• Prevalence and distribution of active trachoma in children of less than five years of age in trachoma endemic regions of Oman in 2005.

  Khandekar R, Mohammed AJ, Al Raisi A, Kurup P, Shah S, Dirir MH, Al Harby S. Khandekar R, et al. Ophthalmic Epidemiol. 2006 Jun;13(3):167-72. doi: 10.1080/09286580600611419. Ophthalmic Epidemiol. 2006. PMID: 16854770
• HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance.

  White AG, Bogh J, Leheny W, Kuchipudi P, Varghese M, al Riyami H, al Hashmi S, Daar AS. White AG, et al. Br J Ophthalmol. 1997 Jun;81(6):431-4. doi: 10.1136/bjo.81.6.431. Br J Ophthalmol. 1997. PMID: 9274403 Free PMC article.
• Oman's progress towards reaching "Ultimate Intervention Goals" for the surgery "S" component of SAFE strategy for the elimination of blinding trachoma in 2008.

  Khandekar R, Al Harthy H, Al Harby S, Al Hinai S, Al Saadi K, Shah S, Prasanna AR, Kurup P, Al Raisi A, Sarvanan N, Al Hadrami K, Krishnaraj V, Sattar AA. Khandekar R, et al. Ophthalmic Epidemiol. 2010 Dec;17(6):360-5. doi: 10.3109/09286586.2010.528852. Ophthalmic Epidemiol. 2010. PMID: 21090910
• The global elimination of blinding trachoma: progress and promise.

  Kumaresan JA, Mecaskey JW. Kumaresan JA, et al. Am J Trop Med Hyg. 2003 Nov;69(5 Suppl):24-8. doi: 10.4269/ajtmh.2003.69.24. Am J Trop Med Hyg. 2003. PMID: 14692677 Review.
• The possibility of eliminating blinding trachoma.

  Mecaskey JW, Knirsch CA, Kumaresan JA, Cook JA. Mecaskey JW, et al. Lancet Infect Dis. 2003 Nov;3(11):728-34. doi: 10.1016/s1473-3099(03)00807-7. Lancet Infect Dis. 2003. PMID: 14592604 Review.